Showing posts with label
Bayer
.
Show all posts
Showing posts with label
Bayer
.
Show all posts
Tuesday, March 11, 2025
Nvidia's interest and investment in Recursion Pharmaceuticals (RXRX) in 2025 could be a game changer for this small-cap!
›
Recursion Pharmaceuticals (NASDAQ: RXRX) is a clinical-stage biotechnology company that integrates advanced technologies across biology...
Friday, July 19, 2024
Bayer, Roche, Moderna, Cronos, Synlogic, Sumitomo, Biogen, Aldevron, are just some of the big companies now partnered with this SynBio, penny stock!
›
Ginkgo Bioworks has established numerous partnerships across various industries, leveraging its synthetic biology platform. Here are some ...
Thursday, June 13, 2024
Consolidation in the BioTech realm is a given going forward. Ginkgo Bioworks technology looks attractive to larger companies in the space!
›
Ginkgo Bioworks, a prominent player in the synthetic biotech market, could be a potential target for acquisition or merger, especially if co...
›
Home
View web version
